CWM
NVS icon

Compass Wealth Management’s Novartis NVS Stock Holding History

Compass Wealth Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.72M Sell
12,097
-650
-5% -$98.6K 0.33% 76
2026
Q2 		$2M Sell
12,747
-100
-0.8% -$15K 0.38% 71
2026
Q1 		$1.96M Sell
12,847
-100
-0.8% -$15.3K 0.49% 62
2025
Q4 		$1.79M Sell
12,947
-250
-2% -$32.7K 0.45% 63
2025
Q3 		$1.69M Sell
13,197
-125
-0.9% -$15.3K 0.38% 70
2025
Q2 		$1.61M Sell
13,322
-878
-6% -$99K 0.38% 71
2025
Q1 		$1.58M Sell
14,200
-800
-5% -$85.2K 0.4% 72
2024
Q4 		$1.46M Sell
15,000
-1,625
-10% -$173K 0.35% 75
2024
Q3 		$1.91M Sell
16,625
-950
-5% -$108K 0.45% 71
2024
Q2 		$1.87M Sell
17,575
-50
-0.3% -$5.02K 0.46% 71
2024
Q1 		$1.7M Sell
17,625
-660
-4% -$67.7K 0.43% 74
2023
Q4 		$1.85M Buy
18,285
+435
+2% +$42K 0.52% 65
2023
Q3 		$1.82M Sell
17,850
-350
-2% -$35.5K 0.57% 59
2023
Q2 		$1.84M Sell
18,200
-150
-0.8% -$15K 0.55% 60
2023
Q1 		$1.69M Hold
18,350
– – 0.54% 65
2022
Q4 		$1.66M Buy
+18,350
New +$1.55M 0.55% 63

Other funds holding NVS

AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Midwest Trust
Midwest Trust Overland Park, Kansas $8.99B AUM 21.14% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
Godsey & Gibb Inc
Godsey & Gibb Inc Richmond, Virginia $1.21B AUM 18.94% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Matthew Goff Investment Advisor
Matthew Goff Investment Advisor Houston, Texas $672M AUM 21.65% 1-Year Est. Return
Eldred Rock Partners
Eldred Rock Partners San Antonio, Texas $451M AUM 38.39% 1-Year Est. Return
Salem Investment Counselors
Salem Investment Counselors Winston Salem, North Carolina $4.01B AUM 48.23% 1-Year Est. Return

Compass Wealth Management's NVS Position: Q3 2026 in Review

Compass Wealth Management reduced its Novartis (NVS) stake by 5.1% in Q3 2026, selling an estimated $98.6K and leaving 12,097 shares worth $1.72M. The position accounts for 0.33% of the portfolio, ranked #76.

Compass Wealth Management first reported a position in NVS in Q4 2022 and has held it in 16 quarters since. The position peaked at $2M in Q2 2026. 447 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Compass Wealth Management held 12,097 shares of Novartis worth $1.72M as of Q3 2026.
  • Compass Wealth Management sold 650 Novartis shares in Q3 2026, an estimated $98.6K.
  • Novartis made up 0.33% of Compass Wealth Management's portfolio in Q3 2026, its #76 holding.
  • Compass Wealth Management first reported a position in Novartis in Q4 2022 and has held it in 16 quarters since.
  • Compass Wealth Management's Novartis position peaked at $2M in Q2 2026.
  • 447 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Compass Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.